More on IMUX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+55.0% Growth)
- Ratings (9.4 Score)
- Holders

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Immunic Inc. (NQ:IMUX)
Delayed: 14.17 -0.47 (3.21%)
Prev. Close $14.64  
Open$14.53 
52 Wk High$ 
52 Wk Low$ 
Day High$15.15 
Day Low$13.92 
P/E N/A  
EPS$ 
Volume252,393 

Friends, Peers and Foes (?): AUTL (more...)

Jun 1, 2026 05:57 PM Form 4 IMMUNIC, INC. For: May 22 Filed by: Lundgren Erik
Jun 1, 2026 05:56 PM Form 3 IMMUNIC, INC. For: Jun 01 Filed by: Lundgren Erik
May 29, 2026 04:33 PM Form DEF 14A IMMUNIC, INC. For: Jun 29
May 28, 2026 07:01 AM Form 8-K IMMUNIC, INC. For: May 28
May 28, 2026 06:30 AM Immunic presents additional data on multiple sclerosis drug candidate
May 28, 2026 06:30 AM Immunic presents phase 2 trial data at multiple sclerosis meeting
May 28, 2026 06:30 AM Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
May 27, 2026 08:43 AM Stifel on Immunic Inc. (IMUX): 'Overall, we see a number of potential avenues for differentiation for VidoCa'
May 27, 2026 07:01 AM Form 8-K IMMUNIC, INC. For: May 22
May 27, 2026 06:30 AM Immunic names Erik Lundgren as new chief executive officer
View All Articles

Entities mentioned with IMUX

View All Entities